Insider Trading June 11, 2026 12:25 PM

Aemetis Director Timothy Alan Offloads $20,500 in Shares Amid Recent Volatility

Insider selling activity coincides with mixed quarterly results and ongoing capital acquisition efforts for the renewable energy firm.

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
AMTX

Aemetis, Inc. (NASDAQ: AMTX) director Simon Timothy Alan executed a transaction involving the disposal of 10,000 shares of common stock on June 10, 2026. The sale, valued at $20,500, occurs against a backdrop of recent stock price fluctuations and the company's recent financial reporting period. This activity provides a snapshot of insider position adjustments within the renewable energy and agricultural sectors.

Aemetis Director Timothy Alan Offloads $20,500 in Shares Amid Recent Volatility
AMTX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • AEMETIS, INC (NASDAQ: AMTX) director Simon Timothy Alan sold 10,000 shares on June 10, 2026, for a total of $20,500, leaving him with 42,632 shares.
  • The company reported first-quarter 2026 earnings that missed analyst expectations, with an EPS of -$0.33 versus a forecast of -$0.28, and revenue of $54.6 million compared to an anticipated $69.4 million.
  • The California Capital Programs & Climate Financing Authority adopted an Initial Resolution for the potential issuance of up to $1.1 billion in tax-exempt bonds for Aemetis projects.

Simon Timothy Alan, serving as a director at AEMETIS, INC (NASDAQ:AMTX), executed a transaction involving the disposal of 10,000 shares of common stock on June 10, 2026. The total value of this divestment was recorded at $20,500. The shares were disposed of at a weighted average price of $2.05 per share. The transactions occurred within a price range of $2.04 to $2.06. Following this sale, Mr. Alan directly holds 42,632 shares of AEMETIS common stock.

The insider sale comes as the stock has declined 18% over the past week, though the company’s shares remain up 45% year-to-date. According to InvestingPro analysis, AMTX appears undervalued at current levels, with a Financial Health score rated as "WEAK." For deeper insights into AMTX’s valuation and financial health, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US stocks.

In other recent news, Aemetis Inc. reported its first-quarter 2026 earnings, which fell short of analyst expectations. The company posted an earnings per share (EPS) of -$0.33, missing the forecasted -$0.28. Revenue also came in below expectations at $54.6 million, compared to the anticipated $69.4 million. Despite these misses, Aemetis experienced a 27% year-over-year revenue growth, along with improvements in gross profit and operating loss. Additionally, the California Capital Programs & Climate Financing Authority adopted an Initial Resolution for the potential issuance of up to $1.1 billion in tax-exempt bonds for Aemetis projects. This resolution allows funds from any issued bonds to be used for qualified and certain prior development costs. These developments reflect the company’s ongoing efforts to secure financing and improve its financial performance.

The intersection of insider transaction activity and corporate financial reporting provides critical data points for market participants. The disposal of shares by a director often warrants examination within the context of broader company performance and sector dynamics. In the renewable energy and agricultural sectors, capital structure and financing availability are paramount. The reported financial metrics highlight the operational challenges and growth trajectories inherent in this space.

  • Insider transaction activity reflects position adjustments by key company personnel.
  • Financial reporting outcomes indicate a divergence between revenue growth and profitability expectations.
  • Capital market initiatives demonstrate strategic efforts to secure funding for project development.

The financial health rating of "WEAK" presents a notable consideration for valuation assessments. While the stock has appreciated significantly over the current year, the recent weekly decline underscores the volatility inherent in the security. The discrepancy between reported revenue growth and profitability metrics illustrates the complex financial landscape of the company.

Risks associated with the company's financial profile include the aforementioned weak financial health rating and the miss on earnings per share expectations. The reliance on external financing mechanisms, such as the potential tax-exempt bonds, introduces dependency on regulatory and capital market conditions. Furthermore, the recent stock price volatility indicates sensitivity to market sentiment and broader sector trends.

Market participants monitoring the renewable energy and agricultural sectors should consider these developments. The interplay between insider trading activity, financial performance, and capital acquisition strategies forms a comprehensive picture of the company's current standing. The ongoing efforts to improve financial performance and secure financing remain central to the company's operational narrative.

Risks

  • The stock has declined 18% over the past week, indicating recent volatility despite a 45% year-to-date gain.
  • InvestingPro analysis rates AMTX's Financial Health score as "WEAK," suggesting potential challenges in the company's fiscal stability.
  • The company's earnings per share and revenue both fell short of analyst expectations, highlighting execution risks against projected financial performance.

More from Insider Trading

NWFL Director Schmalzle Acquires $14,610 in Shares via IRA Jun 11, 2026 Zumiez Director Liliana Gil Valletta Sells 300 Shares on June 9 Jun 11, 2026 Coca-Cola Executive Jennifer Mann Offloads $8.07 Million in Stock Amid Strong Q1 Performance Jun 11, 2026 Brady Corp CEO Nargolwala Acquires $1M in Shares Amid Leadership Transition Jun 11, 2026 Primis Financial Director Increases Stake with $2,362 Stock Purchase Jun 11, 2026